Millipore Sigma Vibrant Logo

OP79 Anti-p21WAF1 (Ab-6) Mouse mAb (22)

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: Anti-CIP1, Anti-SD11, Anti-p21, Anti-WAF

View Products on Sigmaaldrich.com
OP79
  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityHostAntibody Type
      H, M, RMMonoclonal Antibody
      Description
      Overview

      This product has been discontinued.



      Recognizes the ~21 kDa p21WAF1 protein in rat and mouse embryo fibroblast cell lines treated with actinomycin D.
      Catalogue NumberOP79
      Brand Family Calbiochem®
      SynonymsAnti-CIP1, Anti-SD11, Anti-p21, Anti-WAF
      References
      ReferencesAgarwal, M.L., et al. 1995. Proc. Natl. Acad. Sci. USA 92, 8493.
      Chen, Y.Q., et al. 1995. Int. J. Oncology 7, 889.
      Deng, C., et al. 1995. Cell 82, 675.
      El-Deiry, W.S., et al. 1995. Cancer Res. 55, 2910.
      Waldman, T., et al. 1995. Cancer Res. 55, 5187.
      Elbendary, A., et al. 1994. Cell Growth Diff. 5, 1301.
      El-Deiry, W.S., et al. 1994. Cancer Res. 54, 1169.
      Li, R., et al. 1994. Nature 371, 534.
      Michieli, P., et al. 1994. Cancer Res. 54, 3391.
      Noda, A., et al. 1994. Exp. Cell Res. 211, 90.
      El-Deiry, W.S., et al. 1993. Cell 75, 817.
      Gu, Y., et al. 1993. Nature 366, 707.
      Harper, J.W., et al. 1993. Cell 75, 805.
      Xiong, Y., et al. 1993. Nature 366, 701.
      Xiong, Y., et al. 1993. Genes Devel. 7,1572.
      Xiong, Y., et al. 1992. Cell 71, 505.
      Product Information
      FormLiquid
      FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin, pH 7.5.
      Positive controlInduced rat or mouse embryo fibroblasts
      Preservative≤0.1% sodium azide
      Applications
      Application ReferencesEpitope Identification O'Connor. P., NCI, personal communication
      Key Applications Immunoblotting (Western Blotting)
      Immunoprecipitation
      Not Frozen Sections
      Not Paraffin Sections
      Application NotesFrozen Sections (not recommended)
      Immunoblotting (3 µg/ml)
      Immunoprecipitation (1 µg/ml)
      Paraffin Sections (not recommended)
      Application CommentsMaximal p21WAF1 expression requires wild type p53 activity. Treatment of mouse or rat embryo fibroblasts with DNA damaging agents such as actinomycin D induces wild type p53 expression which in turn activates WAF1 expression. Serum stimulation of quiescent cells will give low level WAF1 expression independent of p53 expression. For immunoblotting applications, antigen/antibody complexes are best visualized using chemiluminescence detection methods. Antibody should be titrated for optimal results in individual systems.
      Biological Information
      Immunogenrecombinant, mouse p21WAF1
      ImmunogenMouse
      Epitopewithin amino acids 20-40 of human p21WAF1
      Clone22
      HostMouse
      IsotypeIgG₁
      Species Reactivity
      • Human
      • Mouse
      • Rat
      Antibody TypeMonoclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Yes
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      OP79 0

      Documentation

      Anti-p21WAF1 (Ab-6) Mouse mAb (22) SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-p21WAF1 (Ab-6) Mouse mAb (22) Certificates of Analysis

      TitleLot Number
      OP79

      References

      Reference overview
      Agarwal, M.L., et al. 1995. Proc. Natl. Acad. Sci. USA 92, 8493.
      Chen, Y.Q., et al. 1995. Int. J. Oncology 7, 889.
      Deng, C., et al. 1995. Cell 82, 675.
      El-Deiry, W.S., et al. 1995. Cancer Res. 55, 2910.
      Waldman, T., et al. 1995. Cancer Res. 55, 5187.
      Elbendary, A., et al. 1994. Cell Growth Diff. 5, 1301.
      El-Deiry, W.S., et al. 1994. Cancer Res. 54, 1169.
      Li, R., et al. 1994. Nature 371, 534.
      Michieli, P., et al. 1994. Cancer Res. 54, 3391.
      Noda, A., et al. 1994. Exp. Cell Res. 211, 90.
      El-Deiry, W.S., et al. 1993. Cell 75, 817.
      Gu, Y., et al. 1993. Nature 366, 707.
      Harper, J.W., et al. 1993. Cell 75, 805.
      Xiong, Y., et al. 1993. Nature 366, 701.
      Xiong, Y., et al. 1993. Genes Devel. 7,1572.
      Xiong, Y., et al. 1992. Cell 71, 505.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision03-October-2007 RFH
      SynonymsAnti-CIP1, Anti-SD11, Anti-p21, Anti-WAF
      ApplicationFrozen Sections (not recommended)
      Immunoblotting (3 µg/ml)
      Immunoprecipitation (1 µg/ml)
      Paraffin Sections (not recommended)
      DescriptionPurified mouse monoclonal antibody, generated by immunizing BALB/c x C57B1/6 F1 mice with the specified immunogen and fusing splenocytes with myeloma cells. Recognizes the ~21 kDa p21WAF1 protein.
      BackgroundThe tumor suppressor p53 transcriptionally activates a number of genes including the WAF1/CIP1 gene in response to DNA damage. The ~21 kDa product of the WAF1 gene is found in a complex involving cyclins, cyclin dependent kinases (CDK), and PCNA in normal cells but not transformed cells and appears to be a universal inhibitor of CDK activity. One consequence of p21WAF1 binding to and inhibiting CDKs is to prevent CDK-dependent phosphorylation and subsequent inactivation of the Rb protein which is essential for cell cycle progression. p21WAF1 is, therefore, a potent and reversible inhibitor of cell cycle progression at both the G1 and G2 checkpoints presumably to allow sufficient time for DNA repair to be completed. Irreversible G1 or G2 arrest leads to apoptosis. However, the role of p21WAF1 in apoptosis is less clear although p53-mediated apoptosis leads to increased WAF1 expression. Induction of p21WAF1 in response to DNA damage can occur by both p53-dependent and p53-independent mechanisms, in response to mitogenic stimuli, differentiation, or in tumor cells with mutated p53. Functional p21WAF1 is essential for p53-mediated G1 arrest presumably due to WAF1 inhibition of both CDK activity and PCNA-dependent DNA replication. WAF1 has also been identified as a gene involved in cellular senescence, termed sdi1. Not surprisingly, p21WAF1 overexpression is growth suppressive consistent with its role as an inhibitor of CDKs. By inhibiting Rb inactivation in a p53-dependent fashion, p21WAF1 serves to integrate cell cycle control mediated by p53 and Rb.
      HostMouse
      Immunogen speciesMouse
      Immunogenrecombinant, mouse p21WAF1
      Epitopewithin amino acids 20-40 of human p21WAF1
      Clone22
      IsotypeIgG₁
      Specieshuman, mouse, rat
      Positive controlInduced rat or mouse embryo fibroblasts
      FormLiquid
      FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin, pH 7.5.
      Concentration Label Please refer to vial label for lot-specific concentration
      Preservative≤0.1% sodium azide
      CommentsMaximal p21WAF1 expression requires wild type p53 activity. Treatment of mouse or rat embryo fibroblasts with DNA damaging agents such as actinomycin D induces wild type p53 expression which in turn activates WAF1 expression. Serum stimulation of quiescent cells will give low level WAF1 expression independent of p53 expression. For immunoblotting applications, antigen/antibody complexes are best visualized using chemiluminescence detection methods. Antibody should be titrated for optimal results in individual systems.
      Storage +2°C to +8°C
      Do Not Freeze Yes
      Toxicity Standard Handling
      ReferencesAgarwal, M.L., et al. 1995. Proc. Natl. Acad. Sci. USA 92, 8493.
      Chen, Y.Q., et al. 1995. Int. J. Oncology 7, 889.
      Deng, C., et al. 1995. Cell 82, 675.
      El-Deiry, W.S., et al. 1995. Cancer Res. 55, 2910.
      Waldman, T., et al. 1995. Cancer Res. 55, 5187.
      Elbendary, A., et al. 1994. Cell Growth Diff. 5, 1301.
      El-Deiry, W.S., et al. 1994. Cancer Res. 54, 1169.
      Li, R., et al. 1994. Nature 371, 534.
      Michieli, P., et al. 1994. Cancer Res. 54, 3391.
      Noda, A., et al. 1994. Exp. Cell Res. 211, 90.
      El-Deiry, W.S., et al. 1993. Cell 75, 817.
      Gu, Y., et al. 1993. Nature 366, 707.
      Harper, J.W., et al. 1993. Cell 75, 805.
      Xiong, Y., et al. 1993. Nature 366, 701.
      Xiong, Y., et al. 1993. Genes Devel. 7,1572.
      Xiong, Y., et al. 1992. Cell 71, 505.
      Application referencesEpitope Identification O'Connor. P., NCI, personal communication